Last reviewed · How we verify
SARS-CoV-2 virus vaccines — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
SARS-CoV-2 virus vaccines (SARS-CoV-2 virus vaccines) — Sheba Medical Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| SARS-CoV-2 virus vaccines TARGET | SARS-CoV-2 virus vaccines | Sheba Medical Center | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- SARS-CoV-2 virus vaccines CI watch — RSS
- SARS-CoV-2 virus vaccines CI watch — Atom
- SARS-CoV-2 virus vaccines CI watch — JSON
- SARS-CoV-2 virus vaccines alone — RSS
Cite this brief
Drug Landscape (2026). SARS-CoV-2 virus vaccines — Competitive Intelligence Brief. https://druglandscape.com/ci/sars-cov-2-virus-vaccines. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab